I thought it was an excellent video. I was very h
Post# of 148287
The thing that stood out to me here is that Dr. Yang mentioned that Leronlimab had developed a "niche" within UCLA, where doctors were really beginning to understand it and favor it in certain situations. I think he said the transplant doctors, in particular, had grown comfortable with using Leronlimab. That is pretty impressive to me (not medically trained).
UCLA has used it on 40 patients and I don't think they were ever a trial site. So, they are always going through the eIND process (I think). That is impressive.
(Can someone verify my statement here about UCLA only using via eIND?)